Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00742443 · ClinicalTrials.gov registry record · Phase 3
Juvista in Scar Revision Surgery of Disfiguring Scars
A Phase 3 study, sponsored by Renovo.
- Completed
- Registry status
- Phase 3
- Development phase
- 350
- Enrollment target
NCT00742443 is a Phase 3 study that has completed, run by Renovo. The registered enrollment target is 350 participants.
The verdict
NCT00742443, a Phase 3 study, has completed, sponsored by Renovo.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 350 participants
- Enrollment target
Study Summary
This trial is to determine whether Juvista can prevent scar formation or improve the appearance of scars following scar revision surgery. The trial will involve comparing Juvista to placebo.
Interventions
- DRUG Juvista (avotermin)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2008-12 |
| Est. Completion | 2011-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00742443
The ClinicalTrials.gov registry entry for NCT00742443 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Renovo, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Juvista (avotermin) is the first listed.
NCT00742443 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00742443 about?
NCT00742443 is a clinical study titled "Juvista in Scar Revision Surgery of Disfiguring Scars". This trial is to determine whether Juvista can prevent scar formation or improve the appearance of scars following scar revision surgery. The trial will involve comparing Juvista to placebo.
What is the current status of trial NCT00742443?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 350 participants. The study started on 2008-12. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00742443?
The interventions under investigation include: Juvista (avotermin) (DRUG).
Who is sponsoring clinical trial NCT00742443?
This trial is sponsored by Renovo, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.